<SEC-DOCUMENT>0001104659-25-001476.txt : 20250106
<SEC-HEADER>0001104659-25-001476.hdr.sgml : 20250106
<ACCEPTANCE-DATETIME>20250106213034
ACCESSION NUMBER:		0001104659-25-001476
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250106
DATE AS OF CHANGE:		20250106

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bioceres Crop Solutions Corp.
		CENTRAL INDEX KEY:			0001769484
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-90962
		FILM NUMBER:		25513282

	BUSINESS ADDRESS:	
		STREET 1:		PO BOX 309, UGLAND HOUSE
		CITY:			GEORGE TOWN, GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1-1104
		BUSINESS PHONE:		54 341 486 1122

	MAIL ADDRESS:	
		STREET 1:		OCAMPO 210 BIS, PREDIO CCT
		CITY:			ROSARIO
		STATE:			C1
		ZIP:			2000

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bioceres Group PLC
		CENTRAL INDEX KEY:			0001954863
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D

	BUSINESS ADDRESS:	
		STREET 1:		HIGHDOWN HOUSE, YEOMAN WAY
		CITY:			WORTHING, WEST SUSSEX
		STATE:			X0
		ZIP:			BN99 3HH
		BUSINESS PHONE:		5403414861100

	MAIL ADDRESS:	
		STREET 1:		HIGHDOWN HOUSE, YEOMAN WAY
		CITY:			WORTHING, WEST SUSSEX
		STATE:			X0
		ZIP:			BN99 3HH
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Bioceres Group PLC -->
          <cik>0001954863</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Ordinary Shares, $0.0001 par value</securitiesClassTitle>
      <dateOfEvent>01/03/2025</dateOfEvent>
      <previouslyFiledFlag>false</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0001769484</issuerCIK>
        <issuerCUSIP>G1117K114</issuerCUSIP>
        <issuerName>Bioceres Crop Solutions Corp.</issuerName>
        <address>
          <com:street1>Ocampo 210 bis, Predio CCT</com:street1>
          <com:city>Rosario, Province of Santa Fe</com:city>
          <com:stateOrCountry>C1</com:stateOrCountry>
          <com:zipCode>2000</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Matthew S. Poulter</personName>
          <personPhoneNum>12129039000</personPhoneNum>
          <personAddress>
            <com:street1>1290 Avenue of the Americas</com:street1>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10104</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001954863</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Bioceres Group PLC</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>X0</citizenshipOrOrganization>
        <soleVotingPower>6570815.00</soleVotingPower>
        <sharedVotingPower>21943191.00</sharedVotingPower>
        <soleDispositivePower>6570815.00</soleDispositivePower>
        <sharedDispositivePower>18867112.00</sharedDispositivePower>
        <aggregateAmountOwned>28514006.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>45.4</percentOfClass>
        <typeOfReportingPerson>HC</typeOfReportingPerson>
        <commentContent>Bioceres Group PLC may be deemed to be the ultimate beneficial owner of Shares held by Bioceres LLC and THEO I SCSp as Bioceres LLC is an indirect wholly-owned subsidiary of Bioceres Group PLC, and Bioceres Group PLC owns 96.2 percent of the outstanding equity securities of THEO I SCSp.

Row 8 includes 3,076,079 shares that Bioceres LLC has shareholder rights over pursuant to the Shareholders Agreement, dated as of March 5, 2019, by and between Bioceres LLC, Pedro Enrique Mac Mullen, Maria Marta Mac Mullen and International Property Services Corp. See Exhibit 10.1.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Bioceres LLC</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>DE</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>18443191.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>15367112.00</sharedDispositivePower>
        <aggregateAmountOwned>18443191.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>29.3</percentOfClass>
        <typeOfReportingPerson>HC</typeOfReportingPerson>
        <commentContent>Bioceres LLC is an indirect wholly-owned subsidiary of Bioceres Group PLC. As a result, Bioceres Group PLC may be deemed to be the ultimate beneficial owner of Shares held by Bioceres LLC

Row 8 includes 3,076,079 shares that Bioceres LLC has shareholder rights over pursuant to the Shareholders Agreement, dated as of March 5, 2019, by and between Bioceres LLC, Pedro Enrique Mac Mullen, Maria Marta Mac Mullen and International Property Services Corp. See Exhibit 10.1.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>THEO I SCSp</reportingPersonName>
        <memberOfGroup>a</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>N4</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>3500000.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>3500000.00</sharedDispositivePower>
        <aggregateAmountOwned>3500000.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>5.6</percentOfClass>
        <typeOfReportingPerson>HC</typeOfReportingPerson>
        <commentContent>Bioceres Group PLC owns 96.2 percent of the outstanding equity securities of THEO I SCSp. As a result, Bioceres Group PLC may be deemed to be the ultimate beneficial owner of Shares held by THEO I SCSp.</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Ordinary Shares, $0.0001 par value</securityTitle>
        <issuerName>Bioceres Crop Solutions Corp.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>Ocampo 210 bis, Predio CCT</com:street1>
          <com:city>Rosario, Province of Santa Fe</com:city>
          <com:stateOrCountry>C1</com:stateOrCountry>
          <com:zipCode>2000</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>EXPLANATORY NOTE - This Amendment No. 11 (the "Amendment") amends and supplements the Schedule 13D filed with the Securities and Exchange Commission (the "SEC") on March 14, 2019, (as amended by Amendment No. 1 filed with the SEC on July 2, 2020, Amendment No. 2 filed with the SEC on August 28, 2020, Amendment No. 3 filed with the SEC on November 25, 2020, Amendment No. 4 filed with the SEC on August 6, 2021, Amendment No. 5 filed with the SEC on October 15, 2021, Amendment No. 6 filed with the SEC on April 5, 2022, Amendment No. 7 filed with the SEC on July 25 2022, Amendment No. 8 filed with the SEC on November 15, 2022, Amendment No. 9 filed with the SEC on March 25, 2024 and Amendment No. 10 filed with the SEC on September 20, 2024 (the "Schedule 13D"), by Bioceres Group PLC, Bioceres LLC and Theo I SCSp (each a "Reporting Person", and herein collectively referred as the "Reporting Persons").</commentText>
      </item1>
      <item2>
        <filingPersonName>Bioceres Group PLC, which is the holder of record of 6,570,815 Shares (corresponding to approximately 10.5% of the Issuer's outstanding capital stock) and through its subsidiaries Bioceres LLC and Theo I SCSp, holds an additional 18,867,112 Shares (corresponding to approximately 30.0% of the Issuer's outstanding capital stock);

Bioceres LLC, which is the holder of record of 15,367,112 Shares (corresponding to approximately 24.5% of the Issuer's outstanding capital stock); and

THEO I SCSp, which is the holder of record of 3,500,000 Shares (corresponding to approximately 5.6% of the Issuer's outstanding capital stock).</filingPersonName>
        <principalBusinessAddress>Bioceres Group PLC is Highdown House, Yeoman Way, Worthing, West Sussex, United Kingdom, BN99 3HH;

Bioceres LLC is 1209 Orange Street, Wilmington 19801-1120, County of New Castle; and

THEO I SCSp is 30 boulevard Royal, L-2449 Luxembourg.</principalBusinessAddress>
        <principalJob>Not applicable.</principalJob>
        <hasBeenConvicted>None of the Reporting Persons has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).</hasBeenConvicted>
        <convictionDescription>None of the Reporting Persons has, during the last five years, been a party to civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding, was, or is subject to, a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or state securities laws or finding any violation with respect to such laws.</convictionDescription>
        <citizenship>Bioceres Group PLC is a company organized under the laws of England and Wales;

Bioceres LLC is limited liability company formed under the laws of Delaware; and

THEO I SCSp is a special limited partnership (societe en commandite speciale) incorporated in the Grand Duchy of Luxembourg.</citizenship>
      </item2>
      <item3>
        <fundsSource>This Amendment is being filed to report a decrease in the Shares beneficially owned by the Reporting Persons, as a result of the settlement of certain financial obligations of the Reporting Persons through payment-in-kind made in Shares relating to a private transaction (the "Transaction"). As a result of the foregoing, the Shares owned by the Reporting Persons decreased from 26,513,708 to 25,437,927.

The Items below amend the information disclosed under the corresponding Items of the Schedule 13D as described below. Except as expressly amended and supplemented by this Amendment, the Schedule 13D is not amended or supplemented in any respect. Capitalized terms used but not otherwise defined in this Amendment have the meanings ascribed to such terms in the Schedule 13D.

The aggregate percentages of Shares beneficially owned by the Reporting Persons, and reported in this Amendment, is calculated based on 62,848,483 Shares outstanding, as reported by the Issuer in its annual report on Form 20-F filed with the SEC on October 30, 2024 (File No. 001-38836) (the "Issuer 20-F").</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>The purpose of the Transaction was to fund the payment of financial obligations which were due.

As a result of the Transaction, the Shares owned by the Reporting Persons, which are not subject to the shareholders' agreement described under Item 6 of the Schedule 13D, decreased from 26,513,708 Shares to 25,437,927 Shares. In addition, 3,076,079 Shares which the Reporting Persons have the shared power to vote or to direct the vote of are subject to the shareholders' agreement described under Item 6 of the Schedule 13D. As a result of the foregoing, in the aggregate, the Reporting Persons beneficially own 28,514,006 Shares (corresponding to approximately 45.4% of the Issuer's outstanding capital stock).

Except for the foregoing, the Reporting Persons have no plans or proposals which relate to, or could result in, any of the matters referred to in Item 4 of Schedule 13D.</transactionPurpose>
      </item4>
      <item5>
        <percentageOfClassSecurities>Bioceres Group PLC: Amount beneficially owned: 28,514,006 - Percentage: 45.4%

Bioceres LLC: Amount beneficially owned: 18,443,191 - Percentage: 29.3%

THEO I SCSp: Amount beneficially owned: 3,500,000 - Percentage: 5.6%</percentageOfClassSecurities>
        <numberOfShares>Bioceres Group PLC:
Sole power to vote or to direct the vote: 6,570,815
Shared power to vote or to direct the vote: 21,943,191
Sole power to dispose or to direct the disposition of: 6,570,815
Shared power to dispose or to direct the disposition of: 18,867,112

Bioceres LLC:
Sole power to vote or to direct the vote: --
Shared power to vote or to direct the vote: 18,443,191
Sole power to dispose or to direct the disposition of: --
Shared power to dispose or to direct the disposition of: 15,367,112

THEO I SCSp
Sole power to vote or to direct the vote: --
Shared power to vote or to direct the vote: 3,500,000
Sole power to dispose or to direct the disposition of: --
Shared power to dispose or to direct the disposition of: 3,500,000</numberOfShares>
        <transactionDesc>None of the Reporting Persons has effected any transactions of the Issuer's Shares during the 60 days preceding the date of this report, except as described in Item 4 of this Schedule 13D/A which information is incorporated herein by reference.</transactionDesc>
        <listOfShareholders>Not applicable.</listOfShareholders>
        <date5PercentOwnership>Not applicable.</date5PercentOwnership>
      </item5>
      <item6>
        <contractDescription>Not applicable.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Exhibit 10.1* Shareholders Agreement, dated as of March 5, 2019, by and among Bioceres LLC, Pedro Enrique Mac Mullen, Maria Marta Mac Mullen and International Property Services Corp.
Exhibit 99.1* Joint Filing Agreement dated March 25, 2024, by and among the Reporting Persons.

* Previously filed.</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Bioceres Group PLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Gloria Montaron Estrada</signature>
          <title>Gloria Montaron Estrada/ Attorney-in-Fact</title>
          <date>01/06/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Bioceres LLC</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Gloria Montaron Estrada</signature>
          <title>Gloria Montaron Estrada/ Manager</title>
          <date>01/06/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>THEO I SCSp</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Gloria Montaron Estrada</signature>
          <title>Gloria Montaron Estrada/ Attorney-in-Fact</title>
          <date>01/06/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
